- Sale!
Colour Matt Finshed - Sale!
Colour Matt Finshed - Sale!Colour Matt Finshed
- Sale!
Colour Matt Finshed - Sale!
Colour Matt Finshed - Sale!
Colour Matt Finshed - Sale!
Colour Matt Finshed - Sale!Colour Matt Finshed
- Sale!
Colour Matt Finshed - Sale!Colour Matt Finshed
- Sale!
Colour Matt Finshed - Sale!
Product details
- Publisher : LWW; Twelfth edition (January 7, 2023)
- Language : English
- Hardcover : 2324 pages
- ISBN-10 : 1975184742
- ISBN-13 : 978-1975184742
- Sale!
- Publisher : Springer; 1st ed. 2022 edition (October 19, 2022)
- Language : English
- Hardcover : 335 pages
- ISBN-10 : 3031108388
- ISBN-13 : 978-3031108389
- Sale!
Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges
by This book provides insight into the various immunotherapeutic approaches for the treatment of lung cancers. The chapters of the book discuss the detailed mechanisms of checkpoint inhibitors, co-stimulatory molecules, drugs working in the immunosuppressive environment, and various vaccines for lung cancer. A chapter of the book explores the recent applications of the oncolytic virus in lung cancer treatment and discusses the potential and direction of oncolytic virus-based therapeutic vaccines. The chapter also elucidates the current understanding of the role of Toll-Like Receptors (TLRs) in tumor progression, and the recent progress in utilizing TLR agonists as potential therapeutic agents in lung cancer treatment. Towards the end, the book reviews the applications of stereotactic body radiation therapy (SBRT) and immunotherapy for the treatment of lung cancer. This book provides useful information to a range of audiences including clinical researchers working in the field of lung cancer, and undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences. 99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material. - Sale!
Immune Strategies for Gastrointestinal Cancer (Cancer Immunotherapy 2)
by This book provides an overview of the available evidence surrounding immunotherapy in gastrointestinal cancers, and discusses its future place in clinical practice.Immunotherapy has celebrated some astonishing therapeutic successes in a variety of cancer types and is becoming increasingly relevant in daily clinical practice. Currently, the predominant class of immunotherapeutic drugs is the so-called checkpoint inhibitors, which disengage the physiological brakes on the immune system, enabling a more effective anti-cancer immune response. Malignancies of the gastrointestinal tract, which account for the majority of cancer cases worldwide, are a major cause of morbidity and mortality, creating an urgent need for more effective therapies. A large number of clinical trials have evaluated the efficacy of cancer immunotherapy in gastrointestinal malignancies and demonstrated its potential in certain subsets of patients. This book will appeal to a wide readership, including oncologists, health care professionals in general and biomedical scientists. 99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material. - Sale!
Helicobacter pylori and Gastric Cancer (Current Topics in Microbiology and Immunology 444)
by This volume explores in detail the molecular biology, genetics and immunology of the bacterium Helicobacter pylori that causes serious gastric diseases such as gastric cancer. The book provides in-depth insights into the mechanisms of H. pylori-induced pathogenicity, gives an overview of how the bacterium colonizes the human gut, how it manages to persist in the body and which factors play a role in the development of H. pylori-induced gastric cancer. Furthermore, the interaction between the Gram-negative bacterium and the human gut microbiome is explored, and clinical management and treatment strategies to combat gastric cancer are discussed.Helicobacter pylori is an extremely successful pathogen that persistently colonizes the gut of about 50% of the world’s population. H. pylori and its human host share a long co-evolutionary relationship that dates back for at least last 100,000 years and possibly longer. Infection by thisbacterium is a high-risk factor for the development of gastric diseases, including gastric cancer. Gastric cancer is associated with high morbidity and mortality and represents the 5th most common malignant tumour and the 4th leading cause of cancer-related death worldwide. H. pylori is the first bacterium that has been classified as a type-I carcinogen by the International Agency for Research on Cancer (IARC). Recent research progress identified crucial bacterial, host and environmental factors which control H. pylori-induced gastric malignancy. New studies also suggest that specific human germline mutations and other genetic aberrations have an important impact on H. pylori-induced pathology. In this volume, all these recently discovered mechanisms are reviewed in the light of gastric cancer development, and H. pylori epidemiology, virulence factors, immune evasion, pathophysiology, cancer signalling and novel therapeutic protocols are presented.This volume is aimed at researchers in the fields of immunology, genetics, microbiology and medicine who are interested in the detailed mechanisms of the pathogenicity of this carcinogenic stomach bacterium.99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material. - Sale!
Gastrointestinal Cancers: An Interdisciplinary Approach: An Interdisciplinary Approach (Interdisciplinary Cancer Research 4)
by - Sale!
Physicians’ Cancer Chemotherapy Drug Manual 2024 24th Edition
- Sale!
Cancer Care in Pandemic Times: Building Inclusive Local Health Security in Africa and India: Cancer Care in Africa and India (International Political Economy Series)
by - Sale!
Breast Cancer Research and Treatment: Innovative Concepts (Cancer Treatment and Research Book 188)
by This book focuses on innovative treatment options for breast cancer, including surgery, radiotherapy, systemic therapy and of course immunotherapy that is changing outcomes in some aggressive breast cancer histotypes. Subsequent chapters also address the ongoing emerging research in the screening, diagnostics, and management of all subtypes of breast cancers. All current landscapes and future perspectives in each molecular subtype: luminal, HER2-positive, and triple-negative breast cancers are discussed within the different chapters. Breast cancer is still the most common cancer and cause of cancer deaths among women worldwide. The improvement of breast cancer outcome appears to be strictly related to the validation of precise biomarkers that enable us to better select personalized approaches in breast cancer management. The closing chapters deal with the challenges of conducting research in the era of precision medicine forcancer. The book is edited and authored by leading experts in this field and will be of interest for clinicians and scientists alike. 99Medical Books is offering all kind of Medical books, Medical Exams Qbank, Audio/Video CD’s and DVD’s and almost all the Medical study material. - Sale!
Practical Management of Thyroid Cancer: A Multidisciplinary Approach 3rd Edition
Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic. The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists.Product details
- Publisher : Springer; 3rd ed. 2023 edition (March 1, 2024)
- Language : English
- Hardcover : 415 pages
- ISBN-10 : 3031386043
- ISBN-13 : 978-3031386046
- Sale!
Cancer Consult: Expertise in Clinical Practice Volume 1: Solid Tumors & Supportive Care 2nd Edition
CANCER CONSULTNew edition covering the specialties of hematology, oncology and cellular therapy, now in two volumesCancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, Second Edition includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes:- Up-to-date, clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy and translational cancer research
- Sections on head, neck, thoracic, breast, GI, genitourinary, skin, gynecological and hereditary cancers, amongst other topics
- Streamlined, engaging content to make finding information easier and less time consuming for the reader
- Concise and practical expert perspectives that reference key studies
- References to the latest NCCN, ESMO, ASCO, and other national guidelines
Product details
- Publisher : Wiley; 2nd edition (January 11, 2024)
- Language : English
- Paperback : 752 pages
- ISBN-10 : 1119823730
- ISBN-13 : 978-1119823735
- Sale!
Ovarian Cancer: The “Gynaecological Challenge” from Diagnostic Work-Up to Cytoreduction and Chemotherapy. Volume 2
